These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15731344)

  • 1. Target-dependent on/off switch increases ribozyme fidelity.
    Bergeron LJ; Perreault JP
    Nucleic Acids Res; 2005; 33(4):1240-8. PubMed ID: 15731344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of the SOFA delta ribozyme.
    Bergeron LJ; Reymond C; Perreault JP
    RNA; 2005 Dec; 11(12):1858-68. PubMed ID: 16251383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme.
    Asif-Ullah M; Lévesque M; Robichaud G; Perreault JP
    Curr Gene Ther; 2007 Jun; 7(3):205-16. PubMed ID: 17584038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.
    Bergeron LJ; Ouellet J; Perreault JP
    Curr Med Chem; 2003 Dec; 10(23):2589-97. PubMed ID: 14529473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating a new generation of ribozymes in order to target HCV.
    Lévesque MV; Lévesque D; Brière FP; Perreault JP
    PLoS One; 2010 Mar; 5(3):e9627. PubMed ID: 20224783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.
    Richardson MW; Hostalek L; Dobson M; Hu J; Shippy R; Siwkowski A; Marmur JD; Khalili K; Klotman PE; Hampel A; Rappaport J
    Methods Mol Biol; 2004; 252():339-58. PubMed ID: 15017062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of target RNA molecules greatly modulate the cleavage efficiency of trans-acting delta ribozymes.
    Swiatkowska A; Dutkiewicz M; Ciesiołka J
    Biochemistry; 2007 May; 46(18):5523-33. PubMed ID: 17425288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
    Ivanov SA; Vauléon S; Müller S
    FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modern mode of activation for nucleic acid enzymes.
    Lévesque D; Brière FP; Perreault JP
    PLoS One; 2007 Jul; 2(7):e673. PubMed ID: 17653287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic strategies of the hepatitis delta virus ribozymes.
    Shih IH; Been MD
    Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the hairpin ribozyme for targeting specific RNA sequences.
    Hampel A; DeYoung MB; Galasinski S; Siwkowski A
    Methods Mol Biol; 1997; 74():171-7. PubMed ID: 9204432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
    Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
    Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General acid catalysis by the hepatitis delta virus ribozyme.
    Das SR; Piccirilli JA
    Nat Chem Biol; 2005 Jun; 1(1):45-52. PubMed ID: 16407993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conformational switch controls hepatitis delta virus ribozyme catalysis.
    Ke A; Zhou K; Ding F; Cate JH; Doudna JA
    Nature; 2004 May; 429(6988):201-5. PubMed ID: 15141216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans cleavage of RNA substrates by an HDV-derived ribozyme.
    Lescure F; Blumenfeld M; Thill G; Vasseur M; Tanner NK
    Prog Clin Biol Res; 1993; 382():99-108. PubMed ID: 8502721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.